Lurasidone and heart function in schizophrenia or bipolar disorder
Part of Heart & circulation, Injuries & trauma, Mental health clinical trials.
This study looks at whether lurasidone, a medication for schizophrenia or bipolar disorder, affects how well the left side of the heart pumps. It may help you understand if this treatment is safe for your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with schizophrenia or bipolar disorder
- Your doctor has prescribed lurasidone for your condition
- You have not been diagnosed with coronary artery disease, heart failure, or severe heart valve problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special brain scan to learn how oxygen use in the brain relates to bipolar depression. It may help future treatments, and you will receive lurasidone (a medication) as part of the study.
This study tests whether adding lurasidone to your current antidepressant can help improve depression symptoms. It is for adults who have not gotten enough relief from their current antidepressant alone.
This study is testing how safe and tolerable an investigational medication is over the long term (52 weeks) when added to your current antipsychotic treatment. It's for people with schizophrenia whose symptoms are stable, and it aims to see if the new medication can help without causing serious side effects.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This study tests if a medication called lacosamide can help people with bipolar depression that has not improved with at least two other treatments. It's for those with moderate to severe depression in bipolar I or II.
This trial tests whether adding lumateperone, an antipsychotic medication, to clozapine can improve metabolic health in people with schizophrenia. It aims to see if this combination helps with weight, blood sugar, and cholesterol levels.
Hear when a new Schizophrenia Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.